WO1992002190A1 - Method and system for whitening teeth - Google Patents

Method and system for whitening teeth Download PDF

Info

Publication number
WO1992002190A1
WO1992002190A1 PCT/US1991/005556 US9105556W WO9202190A1 WO 1992002190 A1 WO1992002190 A1 WO 1992002190A1 US 9105556 W US9105556 W US 9105556W WO 9202190 A1 WO9202190 A1 WO 9202190A1
Authority
WO
WIPO (PCT)
Prior art keywords
retainer
teeth
composition
tooth whitening
person
Prior art date
Application number
PCT/US1991/005556
Other languages
French (fr)
Inventor
Harvey N. Silverman
Original Assignee
Silverman Harvey N
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Silverman Harvey N filed Critical Silverman Harvey N
Publication of WO1992002190A1 publication Critical patent/WO1992002190A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C19/00—Dental auxiliary appliances
    • A61C19/06—Implements for therapeutic treatment
    • A61C19/063—Medicament applicators for teeth or gums, e.g. treatment with fluorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C19/00—Dental auxiliary appliances
    • A61C19/06—Implements for therapeutic treatment
    • A61C19/063—Medicament applicators for teeth or gums, e.g. treatment with fluorides
    • A61C19/066—Bleaching devices; Whitening agent applicators for teeth, e.g. trays or strips

Definitions

  • the present invention relates generally to dental treatment and more particularly to a method and system for applying tooth whitening composition to a person's teeth.
  • the method of obtaining whiter teeth includes tooth bonding, capping or in-office dental bleaching procedures. These methods are relatively costly and therefore not widely available to everyone.
  • the in-office dental bleaching procedure involves making an alginate impression of the arch to be treated. From the resultant hydrocal cast, a vacuum-formed soft plastic night guard, approximately 2 mm thick, is fabricated. The custom made tray is then used to apply a tooth whitening substance to the teeth to be whitened.
  • the in- office procedure is fairly expensive and therefore not readily available to the consumers.
  • Tooth whitening substances are currently available in the market.
  • a 10% Carbamide Peroxide also known as perhydrol-urea, hydrogen peroxide carbamide, urea peroxide, or urea hydrogen peroxide, has been recommended for bleaching teeth.
  • Prior use of the chemical by dental clinics has been as oral antiseptic where tooth bleaching was a side effect of extended contact time.
  • application of the substance involves using a cotton tipped applicator or a toothbrush, which does not make it possible for the tooth whitening composition to stay in contact with the tooth for a longer period.
  • the present invention provides a method and system for tooth whitening that is relatively inexpensive and permits the tooth whitening substance to remain in contact with the teeth to be whitened for a relatively longer period of time.
  • Figure 1 is a top perspective view of a retainer used in the present invention, shown before being custom fitted to a user's teeth.
  • Figure 2 is a side elevational view of the retainer of Figure 1, with portion broken away, shown being custom fitted to a user's upper teeth in accordance with the present invention.
  • Figure 3 is a top perspective view of a custom fitted retainer according to the present invention.
  • Figure 4 is a top perspective view of the custom fitted retainer of Figure 3, shown with the attached strap removed and shown with a layer of tooth whitening composition being applied therein in accordance with the present invention.
  • Figure 5 is a top plan view of the retainer of Figure 4 after the application of the tooth whitening composition.
  • Figure 6 is a top perspective view of a storage case for the custom fitted retainer of Figure 3 with the strap removed.
  • a retainer 2 prior to being custom fitted to a user's upper or lower teeth according to the present invention is disclosed in Figure 1.
  • the retainer 2 is substantially U-shaped in plan view and in cross- section.
  • the retainer 2 is preferably made of tasteless, non-toxic, yieldable, soft, plastic material, such as polyethylene obtainable from Brimns, Inc., Buffalo, New York.
  • the retainer 2 becomes soft and moldable when heated so that it can be fitted and molded around the contours of the upper or lower teeth of a user.
  • the retainer 2 has a frontal bite portion 4 and a pair of leg portions 6 extending rearwardly thereof.
  • the retainer 2 includes a bottom wall 8 connected to an inner retaining wall 10 and an outer retaining wall 12 to form a trough 13 for receiving a tooth whitening composition 14, preferably in a gel, as best shown in Figure 2.
  • a strap 16 is secured to the retainer 2.
  • the retainer 2 is similar in initial appearance to a mouth guard, such as disclosed in U.S. Patent 3,073,300, which is hereby incorporated by reference. However, the patent does not show the attached strap 16.
  • a squeeze tube 18 and a nozzle 20 threadedly secured thereto are preferably used to dispense the tooth whitening composition 14.
  • the tooth whitening composition comprises an active ingredient of 10% Carbamide Peroxide (10%) , EDTA disodium, citric acid, Carbopol 940, Triethanolamine, glycerin, and flavors.
  • the EDTA disodium and citric acid provide buffering agents and preservatives to maintain taste and effectiveness of the composition 14.
  • the Carbopol 940, Triethanolamine and glycerin form the media in which the ingredients are contained.
  • the composition is preferably relatively much thicker, thereby allowing for less occurrence of seepage in the back of the throat.
  • composition 14 Although the ingredients of the composition 14 are not harmful to the body even if ingested, the consumer must refrain from swallowing the composition 14 during use.
  • a composition similar to the tooth whitening composition 14 is disclosed in U.S. Patent 3 , 651 ,413, which is hereby incorporated by reference. Several similar products are presently available in the market.
  • a plastic case 22 is used to keep the retainer 2 when not in use.
  • the kit supplied to the consumer includes a pair of retainers 2 for the upper and lower teeth, a tube 18 containing tooth whitening composition 14, a dispensing nozzle 20, and a carrying case 22, preferably one for each of the retainer 2.
  • the retainer 2 is first custom fitted to the person's teeth in a series of steps described below.
  • a pot of water is brought to a full boil at 212 degrees F.
  • the water is then allowed to sit until it stops boiling.
  • the retainer 2 is then held by the end of the strap 16 and placed entirely in the hot water and waved back and forth for approximately 5 seconds at substantially sea level.
  • less immersion time may be required at higher altitudes because of the reduced boiling temperature of water. It is critical that accurate timing be observed. If the retainer 2 is under hot water too long, the material will adhere to itself or lose its basic configuration.
  • the retainer 2 is removed from the hot water and excess water is shaken off.
  • the retainer 2 is then placed immediately around either the upper or lower teeth, centering it around the teeth, as best shown in Figure 2.
  • the retainer 2 will be warm, but will not burn, since it quickly cools as soon as it is removed from the hot water.
  • the retainer 2 preferably is approximately 0.09 inch thick at the base wall 8 and approximately 0.078 inch thick at the walls 10 and 12 so that it will readily become soft and moldable in a relatively short time and to provide for a comfortable wear.
  • the upper and lower teeth are brought together, biting into the retainer 2; the tongue is pressed against the back of the upper teeth and any air and water from the retainer 2 is sucked out; and the fingers are used to mold the retainer 2 around the upper teeth to make a smooth tight fit, making sure that all of the teeth are covered.
  • a mirror is preferably used for best results. It is important that the upper and lower teeth be brought together and the procedure followed strictly at all times during the forming process in order to properly shape the retainer 2 to the contour of the teeth and gums. If a good fit is not obtained, the above procedure may be repeated as many times as necessary, provided that the retainer 2 is not kept under hot water longer than five seconds each time.
  • the retainer 2 is then left in the mouth for approximately 30 seconds and then removed and placed under cold water to retain its new shape.
  • the custom fitted retainer 2 attains teeth impressions 24 after being molded to the shape of the person's teeth, as best shown in Figure 3.
  • the custom fitter retainer 2 is then tried for comfort. When a good fit is determined, the strap 16 is trimmed with scissors.
  • All of the upper or lower teeth should be covered by the custom fitted retainer 2.
  • the custom fitted retainer 2 may be trimmed with scissors.
  • the retainer 2 for the other of the lower and upper teeth is fitted in the same way as discussed above.
  • a very thin layer of the tooth whitening composition 14 is then placed on the inside surfaces of the trough 13 of the custom fitted retainer 2, as best shown in Figure 4.
  • a very thin layer 28 of the tooth whitening composition 14 is applied to the inside surface 26 of the outer wall 6 of the custom fitted retainer 2 such that the composition 14 will be applied to the front surfaces of the teeth to be whitened, as best shown in Figures 4 and 5.
  • the tooth whitening composition 14 is used sparingly so that the minimum amount of composition oozes out of the custom fitted retainer 2 when placed around the teeth.
  • the teeth to be whitened should be brushed before the loaded custom fitted retainer 2 is worn.
  • the custom fitted retainer 2 with the tooth whitening composition 14 is then seated completely and firmly over the teeth.
  • the fingers are used so that the composition 14 covers the surface of the teeth to be whitened. Any excess composition is removed with a facial tissue.
  • the custom fitted retainer 2 is worn approximately 5 to 18 hours per day.
  • the tooth whitening composition 14 is preferably replaced every 1 1/2 hours.
  • the rate of the whitening process is directly related to the period of use of the custom fitted retainer 2 and the frequency of change of the whitening composition 14. The more the custom fitted retainer 2 is used and the more often the whitening composition is replaced, the faster the whitening process proceeds. If the custom fitted retainer 2 is worn for a good part of the day, the desired color change will occur within one to two weeks. If it is worn for only a few hours daily, the process may take longer. Night time only users sometimes require a little more time to achieve maximum benefits, sin-e the whitening composition 14 is not replaced during sleep. It is recommended that the user does not wear both custom fitted retainers at the same time.
  • the consumer use the kit with one of the upper and lower teeth, preferably the upper teeth, until the desired color change is achieved relative to the untreated lower teeth. Treatment for the lower teeth may then proceed after the upper teeth have been whitened to the degree desired by the consumer.
  • the retainer 2 After the custom fitted retainer 2 is taken out of the mouth, the retainer 2 should be rinsed and the teeth should be brushed with a fluoride toothpaste. When not in use, the custom fitted retainer 2 should be kept in its storage case 22. While this invention has been described as having preferred design, it is understood that it is capable of further modification, uses and/or adaptations of the invention following in general the principle of the invention and including such departures from the present disclosure as come within known or customary practice in the art to which the invention pertains, and as may be applied to the essential features set forth, and fall within the scope of the invention or the limits of the appended claims.

Abstract

A method for whitening the teeth of a person, comprises the steps of a retainer (2) made of a plastic material adapted to be moldable when heated for conforming to the shape of one of the upper and lower teeth of the person; heating the retainer (2) until soft and moldable without losing its basic shape; fitting the retainer (2) around one of the upper and lower teeth; applying a layer of tooth whitening composition (14) inside the retainer; wearing the loaded retainer (2) for several hours each day until the teeth to be whitened have become whiter; replacing the tooth whitening composition every 1-2 hours; and repeating the above steps with another retainer for the other of lower and upper teeth.

Description

- I-.
METHOD AND SYSTEM FOR WHITENING TEETH FIELD OF THE INVENTION
The present invention relates generally to dental treatment and more particularly to a method and system for applying tooth whitening composition to a person's teeth.
BACKGROUND OF THE INVENTION Many commercially available toothpastes remove stains through abrasives, which can damage the tooth enamel. Toothpastes are unable to whiten teeth that are naturally yellow or gray in color. The present
method of obtaining whiter teeth includes tooth bonding, capping or in-office dental bleaching procedures. These methods are relatively costly and therefore not widely available to everyone. The in-office dental bleaching procedure involves making an alginate impression of the arch to be treated. From the resultant hydrocal cast, a vacuum-formed soft plastic night guard, approximately 2 mm thick, is fabricated. The custom made tray is then used to apply a tooth whitening substance to the teeth to be whitened. The in- office procedure is fairly expensive and therefore not readily available to the consumers.
Tooth whitening substances are currently available in the market. A 10% Carbamide Peroxide, also known as perhydrol-urea, hydrogen peroxide carbamide, urea peroxide, or urea hydrogen peroxide, has been recommended for bleaching teeth. Prior use of the chemical by dental clinics has been as oral antiseptic where tooth bleaching was a side effect of extended contact time. However, application of the substance involves using a cotton tipped applicator or a toothbrush, which does not make it possible for the tooth whitening composition to stay in contact with the tooth for a longer period. There is therefore a need to provide an apparatus and method for whitening teeth that is fairly inexpensive without requiring a visit to a dentist, that can be used effectively at home and that permits the tooth whitening composition to remain in contact with the teeth to be whitened for a relatively longer period of time.
OBJECTS AND SUMMARY OF THE INVENTION
It is therefore an object of the present invention to provide a method and system for tooth whitening where the tooth whitening substance is permitted to remain in contact with the tooth to be whitened for a relatively longer period of time.
It is another object of the present invention to provide a method and system for tooth whitening where the tooth whitening substance can be applied at home, without requiring a visit to a dentist.
It is still another object of the present invention to provide a method and system for tooth whitening where the tooth whitening substance is carried in a tray which is custom fitted by a user to his teeth at home without a visit to a dentist. In summary, the present invention provides a method and system for tooth whitening that is relatively inexpensive and permits the tooth whitening substance to remain in contact with the teeth to be whitened for a relatively longer period of time.
These and other objects of the present invention will become apparent from the following detailed description.
BRIEF DESCRIPTIONS OF THE DRAWINGS
Figure 1 is a top perspective view of a retainer used in the present invention, shown before being custom fitted to a user's teeth.
Figure 2 is a side elevational view of the retainer of Figure 1, with portion broken away, shown being custom fitted to a user's upper teeth in accordance with the present invention. Figure 3 is a top perspective view of a custom fitted retainer according to the present invention.
Figure 4 is a top perspective view of the custom fitted retainer of Figure 3, shown with the attached strap removed and shown with a layer of tooth whitening composition being applied therein in accordance with the present invention.
Figure 5 is a top plan view of the retainer of Figure 4 after the application of the tooth whitening composition. Figure 6 is a top perspective view of a storage case for the custom fitted retainer of Figure 3 with the strap removed.
DETAILED DESCRIPTION OF THE INVENTION A retainer 2 prior to being custom fitted to a user's upper or lower teeth according to the present invention is disclosed in Figure 1. The retainer 2 is substantially U-shaped in plan view and in cross- section. The retainer 2 is preferably made of tasteless, non-toxic, yieldable, soft, plastic material, such as polyethylene obtainable from Brimns, Inc., Buffalo, New York. The retainer 2 becomes soft and moldable when heated so that it can be fitted and molded around the contours of the upper or lower teeth of a user. The retainer 2 has a frontal bite portion 4 and a pair of leg portions 6 extending rearwardly thereof. The retainer 2 includes a bottom wall 8 connected to an inner retaining wall 10 and an outer retaining wall 12 to form a trough 13 for receiving a tooth whitening composition 14, preferably in a gel, as best shown in Figure 2. A strap 16 is secured to the retainer 2.
The retainer 2 is similar in initial appearance to a mouth guard, such as disclosed in U.S. Patent 3,073,300, which is hereby incorporated by reference. However, the patent does not show the attached strap 16.
A squeeze tube 18 and a nozzle 20 threadedly secured thereto are preferably used to dispense the tooth whitening composition 14. The tooth whitening composition comprises an active ingredient of 10% Carbamide Peroxide (10%) , EDTA disodium, citric acid, Carbopol 940, Triethanolamine, glycerin, and flavors. The EDTA disodium and citric acid provide buffering agents and preservatives to maintain taste and effectiveness of the composition 14. The Carbopol 940, Triethanolamine and glycerin form the media in which the ingredients are contained. The composition is preferably relatively much thicker, thereby allowing for less occurrence of seepage in the back of the throat. Although the ingredients of the composition 14 are not harmful to the body even if ingested, the consumer must refrain from swallowing the composition 14 during use. A composition similar to the tooth whitening composition 14 is disclosed in U.S. Patent 3 , 651 ,413, which is hereby incorporated by reference. Several similar products are presently available in the market. A plastic case 22 is used to keep the retainer 2 when not in use.
OPERATION OF HOME USE AND APPLICATION
The kit supplied to the consumer includes a pair of retainers 2 for the upper and lower teeth, a tube 18 containing tooth whitening composition 14, a dispensing nozzle 20, and a carrying case 22, preferably one for each of the retainer 2. To use the kit, the retainer 2 is first custom fitted to the person's teeth in a series of steps described below.
A pot of water is brought to a full boil at 212 degrees F. The water is then allowed to sit until it stops boiling. Substantially immediately subsequent to the stopping of the boiling of the water, the retainer 2 is then held by the end of the strap 16 and placed entirely in the hot water and waved back and forth for approximately 5 seconds at substantially sea level. A person of ordinary skill in the art will understand that less immersion time may be required at higher altitudes because of the reduced boiling temperature of water. It is critical that accurate timing be observed. If the retainer 2 is under hot water too long, the material will adhere to itself or lose its basic configuration.
After about at least 5 seconds, the retainer 2 is removed from the hot water and excess water is shaken off. The retainer 2 is then placed immediately around either the upper or lower teeth, centering it around the teeth, as best shown in Figure 2. The retainer 2 will be warm, but will not burn, since it quickly cools as soon as it is removed from the hot water. The retainer 2 preferably is approximately 0.09 inch thick at the base wall 8 and approximately 0.078 inch thick at the walls 10 and 12 so that it will readily become soft and moldable in a relatively short time and to provide for a comfortable wear.
Without delay, the upper and lower teeth are brought together, biting into the retainer 2; the tongue is pressed against the back of the upper teeth and any air and water from the retainer 2 is sucked out; and the fingers are used to mold the retainer 2 around the upper teeth to make a smooth tight fit, making sure that all of the teeth are covered. A mirror is preferably used for best results. It is important that the upper and lower teeth be brought together and the procedure followed strictly at all times during the forming process in order to properly shape the retainer 2 to the contour of the teeth and gums. If a good fit is not obtained, the above procedure may be repeated as many times as necessary, provided that the retainer 2 is not kept under hot water longer than five seconds each time. The retainer 2 is then left in the mouth for approximately 30 seconds and then removed and placed under cold water to retain its new shape. The custom fitted retainer 2 attains teeth impressions 24 after being molded to the shape of the person's teeth, as best shown in Figure 3. The custom fitter retainer 2 is then tried for comfort. When a good fit is determined, the strap 16 is trimmed with scissors.
All of the upper or lower teeth should be covered by the custom fitted retainer 2. For more comfortable fit or if too much of the gums are covered, the custom fitted retainer 2 may be trimmed with scissors. The retainer 2 for the other of the lower and upper teeth is fitted in the same way as discussed above.
A very thin layer of the tooth whitening composition 14 is then placed on the inside surfaces of the trough 13 of the custom fitted retainer 2, as best shown in Figure 4. Preferably, a very thin layer 28 of the tooth whitening composition 14 is applied to the inside surface 26 of the outer wall 6 of the custom fitted retainer 2 such that the composition 14 will be applied to the front surfaces of the teeth to be whitened, as best shown in Figures 4 and 5. The tooth whitening composition 14 is used sparingly so that the minimum amount of composition oozes out of the custom fitted retainer 2 when placed around the teeth.
The teeth to be whitened should be brushed before the loaded custom fitted retainer 2 is worn. The custom fitted retainer 2 with the tooth whitening composition 14 is then seated completely and firmly over the teeth. The fingers are used so that the composition 14 covers the surface of the teeth to be whitened. Any excess composition is removed with a facial tissue.
The custom fitted retainer 2 is worn approximately 5 to 18 hours per day. The tooth whitening composition 14 is preferably replaced every 1 1/2 hours. The rate of the whitening process is directly related to the period of use of the custom fitted retainer 2 and the frequency of change of the whitening composition 14. The more the custom fitted retainer 2 is used and the more often the whitening composition is replaced, the faster the whitening process proceeds. If the custom fitted retainer 2 is worn for a good part of the day, the desired color change will occur within one to two weeks. If it is worn for only a few hours daily, the process may take longer. Night time only users sometimes require a little more time to achieve maximum benefits, sin-e the whitening composition 14 is not replaced during sleep. It is recommended that the user does not wear both custom fitted retainers at the same time. It is also recommended that the consumer use the kit with one of the upper and lower teeth, preferably the upper teeth, until the desired color change is achieved relative to the untreated lower teeth. Treatment for the lower teeth may then proceed after the upper teeth have been whitened to the degree desired by the consumer.
After the custom fitted retainer 2 is taken out of the mouth, the retainer 2 should be rinsed and the teeth should be brushed with a fluoride toothpaste. When not in use, the custom fitted retainer 2 should be kept in its storage case 22. While this invention has been described as having preferred design, it is understood that it is capable of further modification, uses and/or adaptations of the invention following in general the principle of the invention and including such departures from the present disclosure as come within known or customary practice in the art to which the invention pertains, and as may be applied to the essential features set forth, and fall within the scope of the invention or the limits of the appended claims.

Claims

I claim;
1. A method for whitening the teeth of a person, comprising the steps of: a) providing a retainer made of a plastic material adapted to be moldable when heated for conforming to the shape of one of the upper and lower teeth of the person; b) heating the retainer until soft and moldable without losing its basic shape; c) fitting the retainer around one of the upper and lower teeth; d) applying a layer of tooth whitening composition inside the retainer; e) wearing the loaded retainer for several hours each day until the teeth to be whitened have become whiter; f) replacing the tooth whitening composition every 1-2 hours; g) repeating the above steps with another retainer for the other of the lower and upper teeth.
2. A method as in Claim 1, and further comprising the step: a) heating the retainer with boiling water.
3. A method as in Claim 1, and further comprising the step of: a) heating the retainer with boiling water for approximately 5 seconds.
4. A method as in Claim 2, and further comprising the step of: a) waving the retainer while completely submerged in boiling water.
5. A method as in Claim 1, and further comprising the step of: a) biting firmly into the retainer immediately after said heating step; b) pressing the tongue against the back of the upper teeth; c) sucking out any air from the first retainer; and d) using the fingers to mold the retainer around the front of one of the upper and lower teeth.
6. A method for whitening teeth as in Claim 5 and further comprising the step of: a) keeping the retainer in the mouth for 30 seconds.
7. A method for whitening teeth as in Claim 6 and further comprising the step of: a) removing the retainer from the mouth; and b) dipping the retainer in cold water.
8. A method as in Claim 7, and further comprising the step of: a) trimming the retainer of any excess material.
9. A method as in Claim 8, and further comprising the step of: a) applying a layer of the tooth whitening composition along an inside front surface of the retainer.
10. A method for wh.tening teeth as in Claim 9 and further comprising the step of: a) wearing the loaded retainer approximately 5-18 hours per day.
11. A method as in Claim 9, and further comprising the step of: a) brushing the teeth before placing the loaded retainer in the mouth.
12. A method as in Claim 10, and further comprising the step of: a) brushing the teeth with fluoride toothpaste after taking the loaded retainer from the mouth.
13. A system for whitening teeth of a person, comprising: a) a custom fitted U-shaped retainer made of a material adapted to be moldable when heated for conforming to the shape of the upper or lower teeth of the person, said retainer being custom fitted by heating said retainer and fitting around the upper or lower teeth; b) said retainer including a front bite portion and a pair of rearwardly extending leg portions therefrom; c) said member including inner and outer retaining walls and a connecting base portion for forming a trough; d) tooth whitening composition disposed in said trough; e) whereby when said retainer loaded with said tooth whitening composition is worn by the person, said composition comes in contact with the teeth to be whitened.
14. A system as in Claim 13, wherein: a) said trough includes front inside surface; and b) said composition is disposed on said inside surface.
15. A system as in Claim 13, wherein: a) said composition comprises 10% Carbamide Peroxide.
16. A system as in Claim 13, wherein: a) said composition consists of 10% Carbamide Peroxide, EDTA disodium, citric acid, Carbopol 940, Triethanolamine, glycerin, and flavors.
17. A system as in Claim 13, wherein: a) said retainer has a thickness range of approximately 0.078-0.09 inch.
18. A kit for whitening the teeth of a person, comprising: a) a U-shaped retainer for each of the upper and lower teeth of a person, said retainer being made of a material adapted to be moldable when heated for conforming to the shape of the upper or lower teeth; b) said retainer including a front bite portion and rearwardly extending leg portions; c) said retainer including inner and outer retaining walls and a connecting base portion for forming a trough for receiving a tooth whitening composition; d) a dispenser for said tooth whitening composition; e) tooth whitening composition comprising 10% Carbamide Peroxide; and f) a case for said retainer.
19. A kit as in Claim 18, wherein: a) said composition consists of 10% Carbamide Peroxide, EDTA disodium, citric acid, Carbopol 940, Triethanolamine, glycerin, and flavors.
20. A kit as in Claim 18, wherein: a) said retainer has a thickness range of approximately 0.078-0.09 inch.
PCT/US1991/005556 1990-08-09 1991-08-09 Method and system for whitening teeth WO1992002190A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US564,753 1983-12-22
US07/564,753 US5165424A (en) 1990-08-09 1990-08-09 Method and system for whitening teeth

Publications (1)

Publication Number Publication Date
WO1992002190A1 true WO1992002190A1 (en) 1992-02-20

Family

ID=24255741

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1991/005556 WO1992002190A1 (en) 1990-08-09 1991-08-09 Method and system for whitening teeth

Country Status (3)

Country Link
US (1) US5165424A (en)
AU (1) AU8611591A (en)
WO (1) WO1992002190A1 (en)

Cited By (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790444B2 (en) 1991-03-18 2004-09-14 New York University Medical Center Anti-TNF antibodies and peptides of human necrosis factor
WO2004084823A2 (en) 2003-03-19 2004-10-07 Abgenix, Inc. Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof
WO2005037214A2 (en) 2003-10-14 2005-04-28 Intermune, Inc. Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication
US7037498B2 (en) 2001-01-05 2006-05-02 Abgenix, Inc. Antibodies to insulin-like growth factor I receptor
US7169386B1 (en) 1991-03-18 2007-01-30 New York University Methods of treating inflammation associated with viral infection with anti-TNF antibodies
WO2007059082A1 (en) 2005-11-10 2007-05-24 Curagen Corporation Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen
US7250298B2 (en) 2004-04-07 2007-07-31 The University Of Chicago Monomeric red fluorescent proteins
EP1970058A1 (en) 1998-08-18 2008-09-17 The Regents of the University of California Office of Technology Transfer Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
EP2093235A1 (en) 2006-02-08 2009-08-26 Alios Biopharma Inc. Hyperglycosylated variants of interferon alfacon-1
EP2112166A2 (en) 1998-12-23 2009-10-28 Pfizer Inc. Human monoclonal antibodies to CTLA-4
US7618626B2 (en) 2004-07-16 2009-11-17 Pfizer Inc Combination treatment for non-hematologic malignancies
EP2177537A2 (en) 2004-01-09 2010-04-21 Pfizer Inc. Antibodies to MAdCAM
WO2011000962A2 (en) 2009-07-03 2011-01-06 Bionor Immuno As Novel therapeutic and diagnostic means
EP2308974A2 (en) 1999-10-14 2011-04-13 Clontech Laboratories Inc. Anthozoa derived chromo/fluoroproteins and methods for using the same
EP2384767A1 (en) 2005-03-24 2011-11-09 Millennium Pharmaceuticals, Inc. Antibodies that bind OV064 and methods of use therefor
EP2390262A1 (en) 2003-05-16 2011-11-30 Intermune, Inc. Synthetic chemokine receptor ligands and methods of use thereof
EP2426150A1 (en) 2006-06-30 2012-03-07 Novo Nordisk A/S Anti-NKG2A antibodies and uses thereof
EP2444420A1 (en) 2005-04-26 2012-04-25 Pfizer Inc. P-Cadherin antibodies
WO2012099871A1 (en) 2011-01-17 2012-07-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Modulation of lrch4 activity and therapeutic application thereof
WO2012153707A1 (en) 2011-05-09 2012-11-15 株式会社ペルセウスプロテオミクス Antibody specifically recognising transferrin receptor
EP2535355A2 (en) 2005-03-23 2012-12-19 Genmab A/S Antibodies against CD38 for treatment of multiple myeloma
WO2013092998A1 (en) 2011-12-23 2013-06-27 Innate Pharma Enzymatic conjugation of antibodies
EP2628753A1 (en) 2008-01-24 2013-08-21 Novo Nordisk A/S Humanized anti-human NKG2A monoclonal antibody
WO2013182662A1 (en) 2012-06-06 2013-12-12 Bionor Immuno As Vaccine
US8664471B2 (en) 2001-12-19 2014-03-04 The University Of Chicago Rapidly maturing fluorescent proteins and methods for using the same
US8679749B2 (en) 2007-11-01 2014-03-25 The University Of Chicago Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation
WO2014073641A1 (en) 2012-11-08 2014-05-15 国立大学法人 宮崎大学 Antibody capable of specifically recognizing transferrin receptor
WO2014123580A1 (en) 2013-02-06 2014-08-14 Inhibrx Llc Non-platelet depleting and non-red blood cell depleting cd47 antibodies and methods of use thereof
EP2769993A1 (en) 2007-12-14 2014-08-27 Novo Nordisk A/S Antibodies against human NKG2D and uses thereof
WO2015007337A1 (en) 2013-07-19 2015-01-22 Bionor Immuno As Method for the vaccination against hiv
WO2015034052A1 (en) 2013-09-05 2015-03-12 国立大学法人 宮崎大学 Antibody which specifically reacts with human integrin a6b4
WO2015164330A1 (en) 2014-04-21 2015-10-29 Millennium Pharmaceuticals, Inc. Anti-psyk antibody molecules and use of same for syk-targeted therapy
WO2015195917A1 (en) 2014-06-18 2015-12-23 Mersana Therapeutics, Inc. Monoclonal antibodies against her2 epitope and methods of use thereof
EP3025727A1 (en) 2008-10-02 2016-06-01 The J. David Gladstone Institutes Methods of treating liver disease
US9427478B2 (en) 2013-06-21 2016-08-30 Innate Pharma Enzymatic conjugation of polypeptides
WO2016177833A1 (en) 2015-05-04 2016-11-10 Bionor Immuno As Dosage regimen for hiv vaccine
WO2017221883A1 (en) 2016-06-20 2017-12-28 武田薬品工業株式会社 Antibody-drug conjugate
US9932393B2 (en) 2002-06-14 2018-04-03 Stowers Institute For Medical Research Antibody that binds murine wise protein
US10036010B2 (en) 2012-11-09 2018-07-31 Innate Pharma Recognition tags for TGase-mediated conjugation
US10071169B2 (en) 2013-06-20 2018-09-11 Innate Pharma Enzymatic conjugation of polypeptides
EP3375791A1 (en) 2009-09-30 2018-09-19 Memorial Sloan Kettering Cancer Center Combination immunotherapy for the treatment of cancer
US10132799B2 (en) 2012-07-13 2018-11-20 Innate Pharma Screening of conjugated antibodies
WO2019014572A1 (en) 2017-07-14 2019-01-17 Pfizer, Inc. Antibodies to madcam
EP3520816A2 (en) 2009-10-23 2019-08-07 Millennium Pharmaceuticals, Inc. Anti-gcc antibody molecules and related compositions and methods
WO2019197310A1 (en) * 2018-04-13 2019-10-17 Koninklijke Philips N.V. Manifold assembly for applying whitening gels and other oral care compounds to mouthpieces
US10611824B2 (en) 2013-03-15 2020-04-07 Innate Pharma Solid phase TGase-mediated conjugation of antibodies
WO2020105621A1 (en) 2018-11-20 2020-05-28 株式会社ペルセウスプロテオミクス Inhibitor of cellular iron uptake
IT201900008376A1 (en) 2019-06-07 2020-12-07 Univ Degli Studi Di Modena E Reggio Emilia ANTIBODIES WITH ANTI-TUMOR ACTIVITY
WO2021045184A1 (en) 2019-09-04 2021-03-11 株式会社ペルセウスプロテオミクス Therapeutic agent for polycythemia
WO2021107082A1 (en) 2019-11-27 2021-06-03 株式会社ペルセウスプロテオミクス Therapeutic agent for carcinomatous peritonitis
EP3909601A1 (en) 2020-05-11 2021-11-17 LeukoCom GmbH A novel antibody binding specifically to human ceacam1/3/5 and use thereof
WO2021247908A1 (en) 2020-06-03 2021-12-09 Bionecure Therapeutics, Inc. Trophoblast cell-surface antigen-2 (trop-2) antibodies
WO2022022662A1 (en) 2020-07-31 2022-02-03 百奥泰生物制药股份有限公司 Cd47 antibody and application thereof
WO2022075439A1 (en) 2020-10-08 2022-04-14 国立大学法人東海国立大学機構 Method for determining sensitivity or medicinal effect of anti-transferrin receptor antibody
WO2022201122A1 (en) 2021-03-26 2022-09-29 Janssen Biotech, Inc. Humanized antibodies against paired helical filament tau and uses thereof
WO2023027164A1 (en) 2021-08-26 2023-03-02 株式会社ペルセウスプロテオミクス Reactive oxygen species (ros) production promoter
WO2023170290A1 (en) 2022-03-11 2023-09-14 Janssen Pharmaceutica Nv Multispecific antibodies and uses thereof
WO2023170295A1 (en) 2022-03-11 2023-09-14 Janssen Pharmaceutica Nv Multispecific antibodies and uses thereof
WO2023170291A1 (en) 2022-03-11 2023-09-14 Janssen Pharmaceutica Nv Multispecific antibodies and uses thereof

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5575654A (en) * 1992-11-24 1996-11-19 Fontenot; Mark G. Apparatus and method for lightening teeth
US5863202A (en) * 1992-11-24 1999-01-26 Fontenot; Mark G. Device and method for treatment of dentition
US5980249A (en) * 1992-11-24 1999-11-09 Folh, Llc Method and device for treatment of dentition
US5416950A (en) * 1993-01-08 1995-05-23 American Harvest, Inc. Cooking system and accessories
US5302374A (en) * 1993-04-21 1994-04-12 Dental Concepts Inc. Oral hygiene system
US5460527A (en) * 1993-05-24 1995-10-24 E-Z Gard Industries, Inc. Composite dental bleaching tray
US5718575A (en) * 1993-08-09 1998-02-17 Big Picture, Inc. Adjustable, customizable performance enhancing dental appliance
US5865619A (en) * 1993-08-09 1999-02-02 Big Picture, Inc. Triple composite performance enhancing dental appliance
US5573399A (en) * 1994-10-24 1996-11-12 Mcclintock, Ii; Robert A. Application for applying a bleaching agent to teeth and method therefor
NL9500373A (en) * 1995-02-24 1996-10-01 Diamond White Avv Method for preparing a combination preparation for bleaching of teeth on the one hand and for skin and mucous membrane disorders on the other and the use thereof.
US5816802A (en) * 1995-09-25 1998-10-06 R. Eric Montgomery Flexible dental tray
DE69637989D1 (en) * 1995-09-25 2009-09-17 Discus Dental Llc Tooth whitening compositions
US5611690A (en) * 1996-04-02 1997-03-18 E. Mishan & Sons, Inc. Method and apparatus for sprayed delivery of tooth bleaching agent
USD387166S (en) * 1996-05-10 1997-12-02 Montgomery Robert E Dental tray
US6371758B1 (en) 1996-08-05 2002-04-16 Bite Tech, Inc. One-piece customizable dental appliance
US5879155A (en) 1996-08-05 1999-03-09 Big Picture, Inc. Adjustable customized composite dental appliance with wire band
US5836761A (en) * 1996-08-05 1998-11-17 Big Picture, Inc. Adjustable customized dental appliance
USD398224S (en) 1996-12-16 1998-09-15 Southpac Trust International, Inc. Floral wrapper
US20020018754A1 (en) 1999-03-15 2002-02-14 Paul Albert Sagel Shapes for tooth whitening strips
US6582708B1 (en) 2000-06-28 2003-06-24 The Procter & Gamble Company Tooth whitening substance
US6102705A (en) * 1997-11-22 2000-08-15 Darnell; Daniel Henry Heated dental tray
US6126443A (en) * 1998-08-13 2000-10-03 3M Innovative Properties Company Medication delivery tray
US6555020B1 (en) * 1998-10-29 2003-04-29 Den-Mat Corporation Stable tooth whitening gels containing high percentages of hydrogen peroxide
US6142780A (en) * 1999-02-01 2000-11-07 3M Innovative Properties Company Custom tray for delivering medication to oral structures
CA2373983C (en) * 1999-07-02 2007-11-13 The Procter & Gamble Company Systems comprising organosiloxane resins for delivering oral care substances and for prolonging such delivery
US6322360B1 (en) 1999-10-22 2001-11-27 3M Innovative Properties Company Medication retention assembly for oral delivery tray
CA2396913A1 (en) * 2000-01-14 2001-07-19 Britesmile, Inc. Tooth whitening and image enhancement center method
ES2313951T3 (en) 2000-03-23 2009-03-16 Dentsply International, Inc. DENTAL WHITENING COMPOSITION.
US20030036037A1 (en) * 2000-03-27 2003-02-20 Zavitsanos Peter D. System and method for whitening teeth
US6497575B2 (en) 2000-03-27 2002-12-24 Peter D. Zavitsanos System and method for whitening teeth
US6626180B1 (en) 2000-09-08 2003-09-30 Bite Tech, Inc. Quadruple composite performance enhancing dental appliance
US6415794B1 (en) 2000-09-08 2002-07-09 Bite Tech, Inc. Composite dental appliance with wedge
US6598605B1 (en) 2000-09-08 2003-07-29 Bite Tech, Inc. Non-softenable, impressionable framework for dental appliances
US8074658B2 (en) 2000-09-08 2011-12-13 Bite Tech, Inc. Composite performance enhancing tethered mouthguard
US6553996B2 (en) 2000-09-08 2003-04-29 Jon D. Kittelsen Dental appliance with antimicrobial additive
US6237601B1 (en) 2000-09-08 2001-05-29 Big Picture, Inc. Cross-cantilever connectors for a dental appliance
US6539943B1 (en) 2000-09-08 2003-04-01 Bite Tech, Inc. Encapsulated composite dental appliance
US8567408B2 (en) 2000-09-08 2013-10-29 Bite Tech, Inc. Composite oral appliances and methods for manufacture
US6257239B1 (en) 2000-09-08 2001-07-10 Bite Tech, Inc. Dental appliance with anti-microbial additive
US6607382B1 (en) * 2000-09-21 2003-08-19 Align Technology, Inc. Methods and systems for concurrent tooth repositioning and substance delivery
US6966773B2 (en) * 2000-11-13 2005-11-22 Keller Duane C Periodontal medicament delivery tray
US6685923B2 (en) 2001-01-25 2004-02-03 Dentsply Research & Development Corp. Tooth whitening material and method of whitening teeth
US6588430B2 (en) 2001-04-06 2003-07-08 Bite Tech, Inc. Composite performance enhancing mouthguard with embedded wedge
US6508251B2 (en) 2001-04-06 2003-01-21 Jon D. Kittelsen Composite mouthguard with palate arch with nonsoftening framework having at least one bridge
US6581604B2 (en) 2001-04-06 2003-06-24 Bite Tech, Inc. Low-density polyethylene dental appliance and mouthguard
US6505627B2 (en) 2001-04-06 2003-01-14 Jon D. Kittelsen Composite mouthguard with palate arch and anterior palate opening
US6510853B1 (en) 2001-04-06 2003-01-28 Jon D. Kittelsen Encapsulated quintuple composite mouthguard
US6505626B2 (en) 2001-04-06 2003-01-14 Jon D. Kittelsen Composite mouthguard with nonsoftenable framework and disconnected anterior impact braces
US6505628B2 (en) 2001-04-06 2003-01-14 Jon D. Kittelsen Quadruple composite performance enhancing mouthguard
US6691710B2 (en) 2001-04-06 2004-02-17 Bite Tech, Inc. Composite mouthguard
US6675806B2 (en) 2001-04-06 2004-01-13 Bite Tech, Inc. Composite mouthguard with elastomeric traction pads and disconnected anterior impact braces
US6491036B2 (en) 2001-04-06 2002-12-10 William A. Cook Low-density polyethylene dental appliance and mouthguard with nucleating agent
US6354837B1 (en) * 2001-05-15 2002-03-12 Steven Jensen Method for bleaching teeth
US20030017435A1 (en) * 2001-07-18 2003-01-23 Ibsen Robert L. Method and system for tooth whitening for long term efficacy
US6895970B1 (en) 2001-12-06 2005-05-24 Eric S. Lawrence Custom tray for reducing dental clenching
US6949240B2 (en) 2002-05-23 2005-09-27 The Procter & Gamble Company Tooth whitening products
US8524200B2 (en) 2002-09-11 2013-09-03 The Procter & Gamble Company Tooth whitening products
US7160111B2 (en) * 2002-09-24 2007-01-09 Twilight Teeth, Inc. Mouthpiece devices and methods to allow UV whitening of teeth
US8172570B2 (en) 2002-09-24 2012-05-08 Twilight Teeth, Inc. Mouthpiece devices and methods to allow UV whitening of teeth
US6820623B2 (en) 2002-11-14 2004-11-23 Bite Tech, Inc. Polyethylene dental appliance and mouthguard with tactifier resin
US7328705B2 (en) 2003-03-10 2008-02-12 Mark Abramson Dental appliance for improving airflow through nasal-pharyngeal airway
US6840771B1 (en) 2003-04-25 2005-01-11 Eugene C. Wagner Tooth whitening appliance
US7114953B1 (en) 2003-04-25 2006-10-03 Wagner Eugene C Tooth whitening appliance having membrane covered applicator
US20050002975A1 (en) * 2003-06-06 2005-01-06 Densen Cao Structures and methods for delivering topical compositions
US20050118115A1 (en) * 2003-10-24 2005-06-02 Fontenot Mark G. Accelerated tooth whitening method, composition and kit
US20050244792A1 (en) * 2004-05-03 2005-11-03 Verdi Anthony J Ultrasonic tooth whitening system
WO2006020128A2 (en) * 2004-07-16 2006-02-23 Osborn Joyce A Tooth whitening lens with bite plate
US8899976B2 (en) 2004-09-24 2014-12-02 Align Technology, Inc. Release agent receptacle
US20060076250A1 (en) * 2004-10-12 2006-04-13 Daniel Kwasney Apparatus for containment of a dental brace
US7168950B2 (en) * 2004-10-18 2007-01-30 3M Innovative Properties Company Orthodontic methods and apparatus for applying a composition to a patient's teeth
PT1809382E (en) * 2004-11-09 2011-02-03 Discus Dental Llc Two-component dental whitening compositions
US20060115785A1 (en) 2004-11-30 2006-06-01 Chunhua Li Systems and methods for intra-oral drug delivery
US7247022B2 (en) * 2005-01-31 2007-07-24 Ultradent Products, Inc. Dental tray system with releasable hold inner and outer dental trays
US20060228307A1 (en) * 2005-04-08 2006-10-12 Cao Group, Inc. Structures and methods for delivering topical compositions
US7452209B2 (en) * 2005-05-02 2008-11-18 Ultradent Products, Inc. Exoskeleton support for placement of a dental treatment strip
US8235052B2 (en) * 2006-01-05 2012-08-07 John Maurello Mouthguard
US8177808B2 (en) * 2007-02-13 2012-05-15 Mullani Nizar A Vein holder
US20090074679A1 (en) * 2007-09-13 2009-03-19 Silverman Harvey N Tooth whitening methods and apparatuses
US8172569B2 (en) 2008-06-12 2012-05-08 Align Technology, Inc. Dental appliance
US8256426B2 (en) 2009-08-12 2012-09-04 Abramson Mark E Modular dental appliance for improving airflow through nasal-pharyngeal airway
US8739599B2 (en) 2010-03-02 2014-06-03 Bio-Applications, LLC Intra-extra oral shock-sensing and indicating systems and other shock-sensing and indicating systems
US8104324B2 (en) 2010-03-02 2012-01-31 Bio-Applications, LLC Intra-extra oral shock-sensing and indicating systems and other shock-sensing and indicating systems
US8689796B2 (en) 2010-05-17 2014-04-08 Shock Doctor, Inc. Mouthguard with linear storage configuration
US8607798B2 (en) 2010-06-02 2013-12-17 Shock Doctor, Inc. Custom mouthguard
USD663486S1 (en) * 2010-06-02 2012-07-10 Shock Doctor, Inc. Custom mouthguard
USD663485S1 (en) * 2010-06-02 2012-07-10 Shock Doctor, Inc. Custom mouthguard
USD688832S1 (en) 2011-05-17 2013-08-27 Shock Doctor, Inc. Mouthguard
US8453650B1 (en) 2012-07-03 2013-06-04 Mdm Mouthpiece
US10085821B2 (en) 2012-07-03 2018-10-02 Mdm Guard for mouth
CA2888199C (en) 2012-10-17 2019-06-25 The Procter & Gamble Company Strip for the delivery of an oral care active and methods for applying oral care actives
AU2014223545B2 (en) 2013-02-26 2017-12-07 Shock Doctor, Inc. Mouthguard with selective flavor components
CA2905980C (en) 2013-03-13 2021-09-21 Shock Doctor, Inc. Clothing article with protective cup
US8784106B1 (en) 2013-05-20 2014-07-22 Eugene C. Wagner Dental preparation delivery system
USD734556S1 (en) * 2013-05-24 2015-07-14 Sportsguard Laboratories, Inc. Mouthguard with lipguard
USD830001S1 (en) 2016-09-27 2018-10-02 Shock Doctor, Inc. Mouthguard
USD830002S1 (en) 2016-09-27 2018-10-02 Shock Doctor, Inc. Mouthguard
USD834258S1 (en) 2016-09-30 2018-11-20 Shock Doctor, Inc. Mouthguard
WO2018063295A1 (en) 2016-09-30 2018-04-05 Shock Doctor, Inc. Mouthguard including a protection portion having heating and softening features
USD841257S1 (en) 2017-07-14 2019-02-19 Shock Doctor, Inc. Mouthguard
USD839485S1 (en) 2017-07-14 2019-01-29 Shock Doctor, Inc. Mouthguard
USD857301S1 (en) 2017-12-15 2019-08-20 Shock Doctor, Inc. Mouth guard
USD854753S1 (en) 2017-12-15 2019-07-23 Shock Doctor, Inc. Mouthguard
US11179622B2 (en) 2018-01-10 2021-11-23 Shock Doctor, Inc. Mouthguard with tapered breathing channel
USD963950S1 (en) 2020-01-28 2022-09-13 Shock Doctor, Inc. Mouthguard
JP1724516S (en) * 2021-12-31 2022-09-12 shell dental instrument

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2833278A (en) * 1956-04-05 1958-05-06 Harold M Ross Protective mouthpiece
US3060935A (en) * 1960-12-15 1962-10-30 Robert H Riddell Means and method for treating diseases of the teeth and gums
US3379193A (en) * 1965-10-11 1968-04-23 Richard P. Monaghan Method of forming and using teeth covers
US4944947A (en) * 1988-04-26 1990-07-31 Newman Martin H Therapeutic dental appliance

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2835628A (en) * 1957-04-01 1958-05-20 Jacob A Saffir Means for treating teeth
US3073300A (en) * 1961-03-24 1963-01-15 Roberts Dental Mfg Co Inc Mouth guard
US3657413A (en) * 1969-08-28 1972-04-18 Block Drug Co Antiseptic composition containing peroxide glycerol and carboxypolymethylene polymer
US3688406A (en) * 1970-08-07 1972-09-05 William I Porter Apparatus for and method of applying decay retardant compositions to teeth
US3894286A (en) * 1974-01-28 1975-07-08 Crystal Tech Inc Temperature compensated voltage tunable circuits using surface wave devices
US3955281A (en) * 1974-12-05 1976-05-11 Pacemaker Corporation Disposable dental tray for topical application of fluoride gel and other dental medications
US4150485A (en) * 1977-09-13 1979-04-24 Kidd Patrick D Liquid paint-on dental restorative process and composition
NL169820C (en) * 1979-05-09 1982-09-01 Gaba Bv DEVICE FOR TREATING A TOOTH.
JPH062174B2 (en) * 1988-09-08 1994-01-12 サンスター株式会社 Mouthpiece

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2833278A (en) * 1956-04-05 1958-05-06 Harold M Ross Protective mouthpiece
US3060935A (en) * 1960-12-15 1962-10-30 Robert H Riddell Means and method for treating diseases of the teeth and gums
US3379193A (en) * 1965-10-11 1968-04-23 Richard P. Monaghan Method of forming and using teeth covers
US4944947A (en) * 1988-04-26 1990-07-31 Newman Martin H Therapeutic dental appliance

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CLINICAL RESERACH ASSOCIATES NEWSLETTER, July 1989. *
HAYWOOD, "Nightguard Vital Bleaching", pp. 173 & 175, CLINICAL RESERACH ASSOCIATES NEWSLETTER, December 1989. *

Cited By (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7226593B2 (en) 1991-03-18 2007-06-05 Centocor, Inc. Methods of treating cachexia with chimeric anti-TNF antibodies
US7128907B2 (en) 1991-03-18 2006-10-31 Centocor, Inc. Methods of treating crohn's disease with anti-TNF antibodies
US6835823B2 (en) 1991-03-18 2004-12-28 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
US6790444B2 (en) 1991-03-18 2004-09-14 New York University Medical Center Anti-TNF antibodies and peptides of human necrosis factor
US6991791B2 (en) 1991-03-18 2006-01-31 New York University School Of Medicine Anti-TNF antibodies and peptides of human tumor necrosis factor
US7223396B2 (en) 1991-03-18 2007-05-29 Centocor, Inc. Methods of treatment of fistulas in Crohn's disease with anti-TNF antibodies
US7070775B2 (en) 1991-03-18 2006-07-04 New York University Recombinant A2-specific TNFα specific antibodies
US7214376B2 (en) 1991-03-18 2007-05-08 New York University Methods of inhibiting TNFα in patients with neoplastic disease
US7135178B2 (en) 1991-03-18 2006-11-14 Centocor, Inc. Methods of treating disseminated intravascular coagulation using anti-TNF antibodies
US7160995B2 (en) 1991-03-18 2007-01-09 New York University DNA encoding anti-TNF antibodies and peptides
US7166284B2 (en) 1991-03-18 2007-01-23 New York University Methods of treating joint inflammation with anti-TNF antibodies
US7169386B1 (en) 1991-03-18 2007-01-30 New York University Methods of treating inflammation associated with viral infection with anti-TNF antibodies
US7179466B2 (en) 1991-03-18 2007-02-20 New York University Methods of treating rheumatoid arthritis by multiple administration of anti-TNF antibodies
US7192584B2 (en) 1991-03-18 2007-03-20 Centocor, Inc. Methods of treating psoriasis with anti-TNF antibodies
US7204985B2 (en) 1991-03-18 2007-04-17 Centocor, Inc. Methods of treating disseminated intravascular coagulation by multiple administration of anti-TNF antibodies
EP1970058A1 (en) 1998-08-18 2008-09-17 The Regents of the University of California Office of Technology Transfer Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
EP3553085A1 (en) 1998-12-23 2019-10-16 Pfizer Inc Human momoclonal antibodies to ctla-4
EP2112166A2 (en) 1998-12-23 2009-10-28 Pfizer Inc. Human monoclonal antibodies to CTLA-4
EP2308974A2 (en) 1999-10-14 2011-04-13 Clontech Laboratories Inc. Anthozoa derived chromo/fluoroproteins and methods for using the same
US7982024B2 (en) 2001-01-05 2011-07-19 Amgen Fremont Inc. Antibodies to insulin-like growth factor I receptor
US7815907B2 (en) 2001-01-05 2010-10-19 Amgen Fremont Inc. Antibodies to insulin-like growth factor I receptor
US7037498B2 (en) 2001-01-05 2006-05-02 Abgenix, Inc. Antibodies to insulin-like growth factor I receptor
US8642037B2 (en) 2001-01-05 2014-02-04 Amgen Fremont Inc. Antibodies to insulin-like growth factor I receptor
EP2796468A2 (en) 2001-01-05 2014-10-29 Pfizer Inc Antibodies to insulin-like growth factor I receptor
US9234041B2 (en) 2001-01-05 2016-01-12 Pfizer Inc. Antibodies to insulin-like growth factor I receptor
US7700742B2 (en) 2001-01-05 2010-04-20 Amgen Fremont Antibodies to insulin-like growth factor I receptor
EP2194067A2 (en) 2001-01-05 2010-06-09 Pfizer Inc. Antibodies to insulin-like growth factor I receptor (IGF-IR)
US8664471B2 (en) 2001-12-19 2014-03-04 The University Of Chicago Rapidly maturing fluorescent proteins and methods for using the same
US9932393B2 (en) 2002-06-14 2018-04-03 Stowers Institute For Medical Research Antibody that binds murine wise protein
WO2004084823A2 (en) 2003-03-19 2004-10-07 Abgenix, Inc. Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof
EP3000886A1 (en) 2003-03-19 2016-03-30 Amgen Fremont Inc. Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof
EP2390262A1 (en) 2003-05-16 2011-11-30 Intermune, Inc. Synthetic chemokine receptor ligands and methods of use thereof
EP2407470A2 (en) 2003-10-14 2012-01-18 F. Hoffmann-La Roche Ltd. Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication
WO2005037214A2 (en) 2003-10-14 2005-04-28 Intermune, Inc. Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication
EP2177537A2 (en) 2004-01-09 2010-04-21 Pfizer Inc. Antibodies to MAdCAM
USRE45847E1 (en) 2004-01-09 2016-01-19 Pfizer Inc. Antibodies to MAdCAM
US7932372B2 (en) 2004-01-09 2011-04-26 Amgen Fremont Inc. Antibodies to MAdCAM
US10259872B2 (en) 2004-01-09 2019-04-16 Pfizer, Inc. Antibodies to MAdCAM
US9328169B2 (en) 2004-01-09 2016-05-03 Pfizer Inc. Human antibodies that bind human MAdCAM
US7910714B2 (en) 2004-04-07 2011-03-22 The University Of Chicago Monomeric red fluorescent proteins
US7671185B2 (en) 2004-04-07 2010-03-02 The University Of Chicago Monomeric red fluorescent proteins
US7250298B2 (en) 2004-04-07 2007-07-31 The University Of Chicago Monomeric red fluorescent proteins
US7618626B2 (en) 2004-07-16 2009-11-17 Pfizer Inc Combination treatment for non-hematologic malignancies
EP3312196A1 (en) 2005-03-23 2018-04-25 Genmab A/S Antibodies against cd38 for treatment of multiple myeloma
EP2551282A2 (en) 2005-03-23 2013-01-30 Genmab A/S Antibodies against CD38 for treatment of multiple myeloma
EP2567976A2 (en) 2005-03-23 2013-03-13 Genmab A/S Antibodies against CD38 for treatment of multiple myeloma
EP2535355A2 (en) 2005-03-23 2012-12-19 Genmab A/S Antibodies against CD38 for treatment of multiple myeloma
EP3153525A1 (en) 2005-03-23 2017-04-12 Genmab A/S Antibodies against cd38 for treatment of multiple myeloma
EP2384767A1 (en) 2005-03-24 2011-11-09 Millennium Pharmaceuticals, Inc. Antibodies that bind OV064 and methods of use therefor
EP3058955A1 (en) 2005-03-24 2016-08-24 Millennium Pharmaceuticals, Inc. Antibodies that bind ov064 and methods of use therefor
EP2444420A1 (en) 2005-04-26 2012-04-25 Pfizer Inc. P-Cadherin antibodies
EP2444419A1 (en) 2005-04-26 2012-04-25 Pfizer Inc. P-Cadherin antibodies
EP2444421A1 (en) 2005-04-26 2012-04-25 Pfizer Inc. P-Cadherin antibodies
EP2548583A2 (en) 2005-11-10 2013-01-23 Curagen Corporation Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen
WO2007059082A1 (en) 2005-11-10 2007-05-24 Curagen Corporation Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen
EP2093235A1 (en) 2006-02-08 2009-08-26 Alios Biopharma Inc. Hyperglycosylated variants of interferon alfacon-1
EP2426150A1 (en) 2006-06-30 2012-03-07 Novo Nordisk A/S Anti-NKG2A antibodies and uses thereof
US8679749B2 (en) 2007-11-01 2014-03-25 The University Of Chicago Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation
EP2769993A1 (en) 2007-12-14 2014-08-27 Novo Nordisk A/S Antibodies against human NKG2D and uses thereof
EP2628753A1 (en) 2008-01-24 2013-08-21 Novo Nordisk A/S Humanized anti-human NKG2A monoclonal antibody
EP3025727A1 (en) 2008-10-02 2016-06-01 The J. David Gladstone Institutes Methods of treating liver disease
WO2011000962A2 (en) 2009-07-03 2011-01-06 Bionor Immuno As Novel therapeutic and diagnostic means
EP3375791A1 (en) 2009-09-30 2018-09-19 Memorial Sloan Kettering Cancer Center Combination immunotherapy for the treatment of cancer
EP3520816A2 (en) 2009-10-23 2019-08-07 Millennium Pharmaceuticals, Inc. Anti-gcc antibody molecules and related compositions and methods
WO2012099871A1 (en) 2011-01-17 2012-07-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Modulation of lrch4 activity and therapeutic application thereof
WO2012153707A1 (en) 2011-05-09 2012-11-15 株式会社ペルセウスプロテオミクス Antibody specifically recognising transferrin receptor
WO2013092998A1 (en) 2011-12-23 2013-06-27 Innate Pharma Enzymatic conjugation of antibodies
US10675359B2 (en) 2011-12-23 2020-06-09 Innate Pharma Enzymatic conjugation of antibodies
WO2013182660A1 (en) 2012-06-06 2013-12-12 Bionor Immuno As Hiv vaccine
EP3967323A2 (en) 2012-06-06 2022-03-16 Bionor Immuno AS Hiv vaccine
WO2013182662A1 (en) 2012-06-06 2013-12-12 Bionor Immuno As Vaccine
US10132799B2 (en) 2012-07-13 2018-11-20 Innate Pharma Screening of conjugated antibodies
WO2014073641A1 (en) 2012-11-08 2014-05-15 国立大学法人 宮崎大学 Antibody capable of specifically recognizing transferrin receptor
EP3564259A2 (en) 2012-11-09 2019-11-06 Innate Pharma Recognition tags for tgase-mediated conjugation
US10036010B2 (en) 2012-11-09 2018-07-31 Innate Pharma Recognition tags for TGase-mediated conjugation
WO2014123580A1 (en) 2013-02-06 2014-08-14 Inhibrx Llc Non-platelet depleting and non-red blood cell depleting cd47 antibodies and methods of use thereof
EP4137518A1 (en) 2013-02-06 2023-02-22 Inhibrx, Inc. Non-platelet depleting and non-red blood cell depleting cd47 antibodies and methods of use thereof
US10611824B2 (en) 2013-03-15 2020-04-07 Innate Pharma Solid phase TGase-mediated conjugation of antibodies
US10071169B2 (en) 2013-06-20 2018-09-11 Innate Pharma Enzymatic conjugation of polypeptides
US9427478B2 (en) 2013-06-21 2016-08-30 Innate Pharma Enzymatic conjugation of polypeptides
US10434180B2 (en) 2013-06-21 2019-10-08 Innate Pharma Enzymatic conjugation of polypeptides
WO2015007337A1 (en) 2013-07-19 2015-01-22 Bionor Immuno As Method for the vaccination against hiv
US10030071B2 (en) 2013-09-05 2018-07-24 University Of Miyazaki Antibody which specifically reacts with human integrin A6B4
WO2015034052A1 (en) 2013-09-05 2015-03-12 国立大学法人 宮崎大学 Antibody which specifically reacts with human integrin a6b4
WO2015164330A1 (en) 2014-04-21 2015-10-29 Millennium Pharmaceuticals, Inc. Anti-psyk antibody molecules and use of same for syk-targeted therapy
WO2015195917A1 (en) 2014-06-18 2015-12-23 Mersana Therapeutics, Inc. Monoclonal antibodies against her2 epitope and methods of use thereof
WO2016177833A1 (en) 2015-05-04 2016-11-10 Bionor Immuno As Dosage regimen for hiv vaccine
WO2017221883A1 (en) 2016-06-20 2017-12-28 武田薬品工業株式会社 Antibody-drug conjugate
EP4212176A1 (en) 2016-06-20 2023-07-19 Genahead Bio, Inc. Antibody-drug conjugate
US11802156B2 (en) 2017-07-14 2023-10-31 Pfizer Inc. Antibodies to MAdCAM
WO2019014572A1 (en) 2017-07-14 2019-01-17 Pfizer, Inc. Antibodies to madcam
WO2019197310A1 (en) * 2018-04-13 2019-10-17 Koninklijke Philips N.V. Manifold assembly for applying whitening gels and other oral care compounds to mouthpieces
CN111970992A (en) * 2018-04-13 2020-11-20 皇家飞利浦有限公司 Manifold assembly for applying whitening gels and other oral care compounds to a mouthpiece
CN111970992B (en) * 2018-04-13 2021-12-07 皇家飞利浦有限公司 Manifold assembly for applying whitening gels and other oral care compounds to a mouthpiece
WO2020105621A1 (en) 2018-11-20 2020-05-28 株式会社ペルセウスプロテオミクス Inhibitor of cellular iron uptake
IT201900008376A1 (en) 2019-06-07 2020-12-07 Univ Degli Studi Di Modena E Reggio Emilia ANTIBODIES WITH ANTI-TUMOR ACTIVITY
WO2021045184A1 (en) 2019-09-04 2021-03-11 株式会社ペルセウスプロテオミクス Therapeutic agent for polycythemia
WO2021107082A1 (en) 2019-11-27 2021-06-03 株式会社ペルセウスプロテオミクス Therapeutic agent for carcinomatous peritonitis
WO2021228746A1 (en) 2020-05-11 2021-11-18 Leukocom Gmbh A novel antibody binding specifically to human ceacam1/3/5 and use thereof
EP3909601A1 (en) 2020-05-11 2021-11-17 LeukoCom GmbH A novel antibody binding specifically to human ceacam1/3/5 and use thereof
WO2021247908A1 (en) 2020-06-03 2021-12-09 Bionecure Therapeutics, Inc. Trophoblast cell-surface antigen-2 (trop-2) antibodies
WO2022022662A1 (en) 2020-07-31 2022-02-03 百奥泰生物制药股份有限公司 Cd47 antibody and application thereof
WO2022075439A1 (en) 2020-10-08 2022-04-14 国立大学法人東海国立大学機構 Method for determining sensitivity or medicinal effect of anti-transferrin receptor antibody
WO2022201122A1 (en) 2021-03-26 2022-09-29 Janssen Biotech, Inc. Humanized antibodies against paired helical filament tau and uses thereof
WO2023027164A1 (en) 2021-08-26 2023-03-02 株式会社ペルセウスプロテオミクス Reactive oxygen species (ros) production promoter
WO2023170290A1 (en) 2022-03-11 2023-09-14 Janssen Pharmaceutica Nv Multispecific antibodies and uses thereof
WO2023170295A1 (en) 2022-03-11 2023-09-14 Janssen Pharmaceutica Nv Multispecific antibodies and uses thereof
WO2023170291A1 (en) 2022-03-11 2023-09-14 Janssen Pharmaceutica Nv Multispecific antibodies and uses thereof

Also Published As

Publication number Publication date
US5165424A (en) 1992-11-24
AU8611591A (en) 1992-03-02

Similar Documents

Publication Publication Date Title
US5165424A (en) Method and system for whitening teeth
JP4718440B2 (en) Pre-formed dental tray and treatment device and method using such dental tray
US9717577B2 (en) Non-custom dental tray having anatomical cuspid-bicuspid cuts and/or V or U-shaped indentation in bottom wall
US4990089A (en) Method and material for brightening teeth
US5575654A (en) Apparatus and method for lightening teeth
US6340301B2 (en) Device for heating the teeth and uses therefor
KR100965439B1 (en) A delivery system for a tooth whitener using a strip of material having low flexural stiffness and a delivery method therefor
US5989569A (en) Delivery system for a tooth whitener using a permanently deformable strip of material
US5076791A (en) Professional home method for bleaching teeth
USRE34196E (en) Method and material for brightening teeth
US5894017A (en) Delivery system for an oral care substance using a strip of material having low flexural stiffness
US6045811A (en) Delivery system for an oral care substance using a permanently deformable strip of material
JP2909040B2 (en) Dental tray and manufacturing method thereof
US20030003421A1 (en) Pre-impregnated disposable dental substance delivery mouthpiece
US7114953B1 (en) Tooth whitening appliance having membrane covered applicator
US6102705A (en) Heated dental tray
US7056118B2 (en) Compositions and devices having a tray-like configuration for delivering a medicament and methods of manufacturing and using such compositions and devices
US20070009857A1 (en) Method and device for whitening teeth
US7052275B2 (en) Kits and methods for bleaching and desensitizing teeth
US7059857B2 (en) Substantially solid desensitizing compositions and devices having a tray-like configuration and methods of manufacturing and using such compositions and devices
US20040002035A1 (en) Teeth treatment device
JP2007509160A (en) Methods, compositions and kits for promoting tooth whitening
US6840771B1 (en) Tooth whitening appliance
JPH06217996A (en) Tooth brushing mouthguard and formation of tooth brushing mounthguard with dentifrice applied to inner surface thereof
KR200249416Y1 (en) Tray for applied fluorides of teeth

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BB BR CA FI HU JP KR NO PL RO SU

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

NENP Non-entry into the national phase

Ref country code: CA